Contributors FDA Health Law Policy Human Subjects Research Immunization Jacob Sherkow Nicholson Price Pharmaceuticals Public Health Rachel Sachs Scientific Evidence Vaccines Why Do Differences in Clinical Trial Design Make It Hard to Compare COVID-19 Vaccines? Read more: Why Do Differences in Clinical Trial Design Make It Hard to Compare COVID-19 Vaccines?
COVID and the Law FDA Health Law Policy Human Subjects Research Patient Care Pharmaceuticals Public Health Scientific Evidence Vaccines “Stick to the Science”? FDA, Ethics, and Pandemics Read more: “Stick to the Science”? FDA, Ethics, and Pandemics
Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Pharmaceuticals Public Health Rachel Sachs Vaccines What’s the Difference Between Vaccine Approval (BLA) and Authorization (EUA)? Read more: What’s the Difference Between Vaccine Approval (BLA) and Authorization (EUA)?
Aaron S. Kesselheim Generic Drugs Health Care Finance Health Care Reform Health Law Policy Insurance Medicare/Medicaid Patient Care Pharmaceuticals Resource Allocation New Rule Might Increase Out-of-Pocket Drug Costs for Patients Read more: New Rule Might Increase Out-of-Pocket Drug Costs for Patients
Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Vaccines How Can Policymakers Overcome the Hurdles to Scaling up Antibody Manufacturing? Read more: How Can Policymakers Overcome the Hurdles to Scaling up Antibody Manufacturing?
Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Vaccines Why Aren’t Therapeutic Antibodies Being Used More to Treat COVID-19? Read more: Why Aren’t Therapeutic Antibodies Being Used More to Treat COVID-19?
Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Vaccines What Can Policymakers Learn from the Slow COVID-19 Vaccine Rollout? Read more: What Can Policymakers Learn from the Slow COVID-19 Vaccine Rollout?
COVID and the Law FDA Health Law Policy Human Subjects Research Patient Care Pharmaceuticals Public Health Scientific Evidence Vaccines From 9/11 to COVID-19: A Brief History of FDA Emergency Use Authorization Read more: From 9/11 to COVID-19: A Brief History of FDA Emergency Use Authorization
Featured Health Law Policy Judicial Opinions Off-Label Use Pediatrics Pharmaceuticals Public Health Race Scientific Evidence Social Determinants of Health Vaccines Can Schools Require the COVID-19 Vaccine? Education, Equity, and the Courts Read more: Can Schools Require the COVID-19 Vaccine? Education, Equity, and the Courts
Contributors FDA Health Law Policy Human Subjects Research Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Scientific Evidence Vaccines How Can Policymakers Encourage COVID-19 Vaccine Trials for Children? Read more: How Can Policymakers Encourage COVID-19 Vaccine Trials for Children?